1. Home
  2. CYCC vs AGFY Comparison

CYCC vs AGFY Comparison

Compare CYCC & AGFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYCC
  • AGFY
  • Stock Information
  • Founded
  • CYCC 1992
  • AGFY 2016
  • Country
  • CYCC Malaysia
  • AGFY United States
  • Employees
  • CYCC N/A
  • AGFY N/A
  • Industry
  • CYCC Biotechnology: Pharmaceutical Preparations
  • AGFY Military/Government/Technical
  • Sector
  • CYCC Health Care
  • AGFY Consumer Discretionary
  • Exchange
  • CYCC Nasdaq
  • AGFY Nasdaq
  • Market Cap
  • CYCC 47.6M
  • AGFY 41.0M
  • IPO Year
  • CYCC N/A
  • AGFY 2021
  • Fundamental
  • Price
  • CYCC $0.35
  • AGFY $22.35
  • Analyst Decision
  • CYCC Strong Buy
  • AGFY
  • Analyst Count
  • CYCC 1
  • AGFY 0
  • Target Price
  • CYCC $11.00
  • AGFY N/A
  • AVG Volume (30 Days)
  • CYCC 7.1M
  • AGFY 38.5K
  • Earning Date
  • CYCC 05-13-2025
  • AGFY 05-20-2025
  • Dividend Yield
  • CYCC 43.71%
  • AGFY N/A
  • EPS Growth
  • CYCC N/A
  • AGFY N/A
  • EPS
  • CYCC N/A
  • AGFY N/A
  • Revenue
  • CYCC $43,000.00
  • AGFY $9,680,000.00
  • Revenue This Year
  • CYCC $137.21
  • AGFY N/A
  • Revenue Next Year
  • CYCC N/A
  • AGFY N/A
  • P/E Ratio
  • CYCC N/A
  • AGFY N/A
  • Revenue Growth
  • CYCC N/A
  • AGFY N/A
  • 52 Week Low
  • CYCC $0.17
  • AGFY $2.71
  • 52 Week High
  • CYCC $4.00
  • AGFY $84.44
  • Technical
  • Relative Strength Index (RSI)
  • CYCC 65.97
  • AGFY 65.00
  • Support Level
  • CYCC $0.23
  • AGFY $13.22
  • Resistance Level
  • CYCC $0.30
  • AGFY $27.67
  • Average True Range (ATR)
  • CYCC 0.06
  • AGFY 2.50
  • MACD
  • CYCC 0.01
  • AGFY 0.81
  • Stochastic Oscillator
  • CYCC 68.57
  • AGFY 63.18

About CYCC Cyclacel Pharmaceuticals Inc.

Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib and plogosertib.

About AGFY Agrify Corporation

Agrify Corp is a leading provider of innovative cultivation and extraction solutions for the cannabis industry, bringing data, science, and technology to the forefront of the market. Its proprietary micro-environment-controlled Agrify Vertical Farming Units (VFUs) enable cultivators to produce high-quality products The products offered by the company include Integrated Grow Racks, LED Grow Lights, Hydroponics, and Vertical Farming Units.

Share on Social Networks: